BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -33.08%232.49M | -63.85%763.05M | -63.82%639.19M | -47.41%511.17M | 11.67%347.42M | 113.82%2.11B | 169.19%1.77B | 141.27%972.02M | 79.45%311.12M | 47.05%987.12M |
Operating revenue | -33.08%232.49M | -63.85%763.05M | -63.82%639.19M | -47.41%511.17M | 11.67%347.42M | 113.82%2.11B | 169.19%1.77B | 141.27%972.02M | 79.45%311.12M | 47.05%987.12M |
Total operating cost | -34.12%316.08M | -21.58%1.45B | -22.45%1.09B | 3.88%801.31M | 80.52%479.8M | 141.46%1.85B | 185.78%1.4B | 154.12%771.37M | 105.96%265.78M | 69.21%766.57M |
Operating cost | -39.29%232.8M | -26.47%1.09B | -28.47%816.68M | -1.34%610.71M | 93.37%383.46M | 204.49%1.48B | 282.71%1.14B | 243.09%618.98M | 172.29%198.3M | 89.96%485.68M |
Operating tax surcharges | -29.72%1.64M | 10.17%15.14M | 10.12%10.88M | 8.33%7.32M | 0.23%2.33M | 23.67%13.75M | 48.77%9.88M | 43.83%6.75M | 4.89%2.32M | 50.75%11.12M |
Operating expense | 5.92%8M | -30.65%30.55M | -19.00%23.1M | -5.90%17.22M | -12.75%7.55M | 37.56%44.05M | 30.93%28.52M | 29.12%18.3M | 31.86%8.65M | -2.92%32.02M |
Administration expense | 2.45%37.59M | -0.81%140.4M | 3.83%101.25M | 19.54%71.87M | 9.01%36.69M | 5.26%141.55M | 3.93%97.52M | -4.01%60.12M | 7.68%33.66M | 26.63%134.48M |
Financial expense | -23.01%15.04M | 188.10%68.34M | 806.14%54.06M | 1,516.96%38.14M | 4,128.50%19.54M | 162.28%23.72M | -35.90%5.97M | -48.49%2.36M | -66.58%462.09K | 148.68%9.04M |
-Interest expense (Financial expense) | -36.92%13.86M | 45.17%76.29M | 131.10%53.53M | 162.75%44.73M | 187.51%21.97M | 99.58%52.55M | 60.31%23.16M | 111.27%17.03M | 121.01%7.64M | 260.95%26.33M |
-Interest Income (Financial expense) | 32.05%-1.65M | 61.60%-11.87M | 49.11%-10.98M | 56.99%-7.1M | 69.48%-2.43M | -73.61%-30.9M | -263.58%-21.57M | -273.38%-16.51M | -262.67%-7.96M | 29.30%-17.8M |
Research and development | -30.52%21.01M | -26.41%109.67M | -31.55%79.22M | -13.58%56.05M | 35.07%30.24M | 58.15%149.03M | 93.62%115.74M | 75.07%64.86M | 51.25%22.39M | 35.83%94.23M |
Credit Impairment Loss | 156.12%4.47M | 124.79%3.66M | 242.37%18.36M | 5,708.08%6.88M | -171.02%-7.96M | 26.20%-14.78M | 27.96%-12.89M | 99.00%-122.71K | 418.53%11.21M | -270.75%-20.02M |
Asset Impairment Loss | --3.45M | -2,932.09%-1.03B | -12,402.84%-266.2M | -559,037.07%-288.03M | --0 | -74.46%-33.92M | 69.57%-2.13M | 99.26%-51.51K | 164.92%47.55K | -698.71%-19.45M |
Other net revenue | ||||||||||
Invest income | 101.95%574.35 | 226.84%3.7M | ---- | -405.56%-435.92K | 97.33%-29.52K | -58.83%-2.92M | 77.47%-86.23K | 79.66%-86.23K | -234.68%-1.11M | -82.40%-1.84M |
Asset deal income | 4,807.22%852.41K | -92.44%119.78K | -160.01%-339.19K | -97.99%14.36K | 95.64%-18.11K | 7.67%1.59M | 410.31%565.21K | 66,811.28%712.88K | -39,084.15%-415.34K | 134,279.96%1.47M |
Other revenue | 67.54%7.9M | 77.15%29.54M | 129.61%49.96M | 23.28%17.58M | -52.52%4.72M | -9.86%16.67M | 162.88%21.76M | 159.28%14.26M | 299.53%9.94M | 114.47%18.5M |
Operating profit | 50.68%-66.92M | -842.13%-1.68B | -271.92%-644.24M | -357.31%-554.14M | -308.69%-135.68M | 13.64%226.39M | 150.61%374.73M | 153.11%215.36M | 51.58%65.01M | -8.63%199.21M |
Add:Non operating Income | -93.30%251.81K | -88.08%3.79M | 318.10%3.28M | 735.09%3.25M | 2,197.08%3.76M | 8,028.84%31.79M | 219.25%783.45K | 159.14%389.64K | 306.48%163.72K | 304.16%391.08K |
Less:Non operating expense | 198.36%1.72M | -80.04%937.58K | 224.65%2.57M | -40.25%380.94K | 52.48%575.6K | 65.66%4.7M | 53.76%791.94K | 343.09%637.59K | 69,161.90%377.48K | 978.02%2.84M |
Total profit | 48.39%-68.38M | -761.68%-1.68B | -271.74%-643.53M | -356.27%-551.26M | -304.47%-132.49M | 28.83%253.48M | 151.06%374.72M | 152.80%215.11M | 50.94%64.8M | -9.68%196.76M |
Less:Income tax cost | 1,449.89%20.82M | -330.18%-169.47M | -146.34%-45.88M | -186.70%-52.21M | -90.07%1.34M | 750.21%73.63M | 479.31%99.01M | 591.02%60.22M | 81.72%13.53M | -77.08%8.66M |
Net profit | 33.35%-89.2M | -938.33%-1.51B | -316.77%-597.65M | -422.21%-499.05M | -361.03%-133.84M | -4.39%179.85M | 108.61%275.71M | 102.79%154.89M | 44.48%51.27M | 4.46%188.1M |
Net profit from continuing operation | 33.35%-89.2M | -938.33%-1.51B | -316.77%-597.65M | -422.21%-499.05M | -361.03%-133.84M | -4.39%179.85M | 108.61%275.71M | 102.79%154.89M | 44.48%51.27M | 4.46%188.1M |
Less:Minority Profit | 101.65%69.64K | -134.66%-12.42M | -126.61%-10.45M | -127.07%-6.27M | -170.67%-4.23M | 240.23%35.84M | 374.65%39.28M | 464.90%23.15M | 390.62%5.98M | 106.55%10.53M |
Net profit of parent company owners | 31.12%-89.27M | -1,138.31%-1.5B | -348.36%-587.2M | -474.07%-492.79M | -386.18%-129.61M | -18.90%144.02M | 90.84%236.43M | 82.27%131.74M | 32.16%45.29M | 1.49%177.57M |
Earning per share | ||||||||||
Basic earning per share | 30.43%-0.16 | -1,160.00%-2.65 | -347.62%-1.04 | -482.61%-0.88 | -387.50%-0.23 | -32.43%0.25 | 50.00%0.42 | 43.75%0.23 | 0.00%0.08 | -5.13%0.37 |
Diluted earning per share | 30.43%-0.16 | -1,164.00%-2.66 | -347.62%-1.04 | -482.61%-0.88 | -387.50%-0.23 | -32.43%0.25 | 50.00%0.42 | 43.75%0.23 | 0.00%0.08 | -5.13%0.37 |
Other composite income | 49.30%-5.64M | -133.95%-11.12M | 3,102.33%32.76M | |||||||
Other composite income of parent company owners | ---- | 49.30%-5.64M | ---- | ---- | ---- | -133.95%-11.12M | ---- | ---- | ---- | 3,102.33%32.76M |
Total composite income | 33.35%-89.2M | -996.92%-1.51B | -316.77%-597.65M | -422.21%-499.05M | -361.03%-133.84M | -23.60%168.73M | 108.61%275.71M | 102.79%154.89M | 44.48%51.27M | 21.96%220.86M |
Total composite income of parent company owners | 31.12%-89.27M | -1,229.45%-1.5B | -348.36%-587.2M | -474.07%-492.79M | -386.18%-129.61M | -36.82%132.89M | 90.84%236.43M | 82.27%131.74M | 32.16%45.29M | 19.51%210.33M |
Total composite income of minority owners | 101.65%69.64K | -134.66%-12.42M | -126.61%-10.45M | -127.07%-6.27M | -170.67%-4.23M | 240.23%35.84M | 374.65%39.28M | 464.90%23.15M | 390.62%5.98M | 106.55%10.53M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.